RNAC Shares Outstanding History — Cartesian Therapeutics Share Count Over Time

As of 4/23/2026 Cartesian Therapeutics has 29.38 million RNAC shares outstanding. Investors often track the RNAC shares outstanding history to compare shareholder return trends against the change in share count over time.

This page shows RNAC share count trends over time, with 12 historical shares outstanding datapoints presented, dating back to 8/4/2023.

Quick links: Shares Outstanding History Table  |  Shares Outstanding History Chart  |  About Cartesian Therapeutics
RNAC Shares Outstanding History



Below is a table of the RNAC shares outstanding history going back to 8/4/2023:

Date RNAC Shares Outstanding
8/4/20235.11M
11/10/20235.17M
3/1/20245.40M
5/3/202417.80M
8/7/202421.38M
11/1/202425.41M
2/28/202525.91M
4/30/202525.95M
8/1/202526.00M
10/31/202526.00M
2/28/202626.51M
4/23/202629.38M

Also see: RNAC Market Cap History
RNAC YTD Return
RNAC Historical Shares Outstanding:
+90.15% CAGR
RNAC Historical Shares Outstanding: +90.15% CAGR

Mouse over chart for data details
8/4/2023 ...4/23/2026
Cartesian Therapeutics, Inc. is a clinical-stage company. Co. is engaged in developing messenger ribonucleic acids (mRNA) cell therapies for the treatment of autoimmune diseases. It is leveraging its proprietary technology and manufacturing platform, RNA Armory, to develop mRNA cell therapies for autoimmune diseases. Its lead asset e, Descartes-08, is an autologous mRNA chimeric antigen receptor T-cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), that the Co. is developing for the treatment of autoimmune diseases. Descartes-08 is in Phase II clinical development. Descartes-15 is a next-generation, autologous anti-BCMA mRNA CAR-T. We show 12 historical shares outstanding datapoints in our coverage of RNAC's shares outstanding history.

Understanding the changing numbers of RNAC shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like RNAC versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching RNAC by allowing them to research RNAC shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree RNAC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance
Cartesian Therapeutics (RNAC) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

RNAZ Shares Outstanding History
RNTX Shares Outstanding History
RNXT Shares Outstanding History
RPHM Shares Outstanding History
RPID Shares Outstanding History
RPRX Shares Outstanding History
RSLS Shares Outstanding History
RTIX Shares Outstanding History
RTRX Shares Outstanding History
RTTR Shares Outstanding History
More Healthcare companies »
 

RNAC Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.